Alluvi Tirzepatide 40mg for sale in UK

A 40mg Tirzepatide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation. MANDATORY DISCLAIMER: This product is used solely for in vitro experiments and cannot be: (1) Used in clinical trials involving humans, (2) Administered to humans as part of an experiment or investigation, or (3) Supplied to another party for human investigational use. The information provided is for educational purposes only.

Alluvi Tirzepatide 40mg – Advanced Peptide for Research Applications

Alluvi Tirzepatide 40mg is a high-strength, research-grade peptide developed for advanced laboratory and scientific use. Known for its role in metabolic pathway research, Tirzepatide has gained significant attention in peptide studies.

This 40mg format provides higher concentration and extended usability, making it ideal for research environments requiring precision and consistency.

What is Tirzepatide?

Tirzepatide is a dual agonist peptide studied for its interaction with:

• GLP-1 (Glucagon-like peptide-1) receptors
• GIP (Glucose-dependent insulinotropic polypeptide) receptors

Its dual-action mechanism makes it a key focus in metabolic, endocrine, and hormonal research.

Product Specifications

• Product Name: Alluvi Tirzepatide 40mg
• Dosage: 40mg
• Purity: High-grade / lab-tested
• Category: Research peptide
• Brand: Alluvi
• Use: For laboratory research purposes only